Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
crispr
2
×
deals
editas medicine
life sciences
national blog main
rare diseases
2
×
san francisco blog main
abalos therapeutics
abbvie
acetonid
achillion pharmaceuticals
aglios therapeutics
alexion pharmaceuticals
allergan
alzheimer's disease
amy peterson
aresenalbio
armo biosciences
asklepios biopharmaceutical
azitra
boston
boulder/denver blog main
boulder/denver top stories
bridgebio
cancer
cancer immunotherapy
checkmate pharmaceuticals
chemotherapy
clinical trials
crispr therapeutics
cynthia collins
cyteir therapeutics
cytomx therapeutics
dan brown
dana washburn
detroit blog main
detroit top stories
What
abbvie
alliance
bails
bio
biotech
brand
bridgebio
capital
car
develop
drugs
editas
editing
emerges
exits
experimental
firm
gene
genetic
grab
headlines
ichnos
invest
life
medicines
millions
new
pact
partnership
pharmaceutical
pruning
research
returning
rights
roundup
science
tens
terminated
treatment
typically
Language
unset
2
×
Current search:
unset
×
" rare diseases "
×
crispr
×
@xconomy.com
3 years ago
AbbVie Exits Editas Alliance, Pruning Another Genetic Medicines Pact
@xconomy.com
4 years ago
Bio Roundup: Ichnos Emerges, Beyond CAR-T, BridgeBio Bails & More
